[HTML][HTML] The importance of the RET gene in thyroid cancer and therapeutic implications

D Salvatore, M Santoro, M Schlumberger - Nature Reviews …, 2021 - nature.com
Since the discovery of the RET receptor tyrosine kinase in 1985, alterations of this protein
have been found in diverse thyroid cancer subtypes. RET gene rearrangements are …

Hirschsprung disease, associated syndromes and genetics: a review

J Amiel, E Sproat-Emison, M Garcia-Barcelo… - Journal of medical …, 2008 - jmg.bmj.com
Hirschsprung disease (HSCR, aganglionic megacolon) represents the main genetic cause
of functional intestinal obstruction with an incidence of 1/5000 live births. This …

Hirschsprung disease, associated syndromes, and genetics: a review

J Amiel, S Lyonnet - Journal of medical genetics, 2001 - jmg.bmj.com
Hirschsprung disease (HSCR, aganglionic megacolon) is the main genetic cause of
functional intestinal obstruction with an incidence of 1/5000 live births. This developmental …

RET tyrosine kinase signaling in development and cancer

E Arighi, MG Borrello, H Sariola - Cytokine & growth factor reviews, 2005 - Elsevier
The variety of diseases caused by mutations in RET receptor tyrosine kinase provides a
classic example of phenotypic heterogeneity. Gain-of-function mutations of RET are …

[HTML][HTML] Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world

M Stefani - Biochimica et biophysica acta (BBA)-Molecular basis of …, 2004 - Elsevier
The data reported in the past 5 years have highlighted new aspects of protein misfolding
and aggregation. Firstly, it appears that protein aggregation may be a generic property of …

The GDNF/RET signaling pathway and human diseases

M Takahashi - Cytokine & growth factor reviews, 2001 - Elsevier
Glial cell line-derived neurotrophic factor (GDNF) and related molecules, neurturin, artemin
and persephin, signal through a unique multicomponent receptor system consisting of RET …

Structure and chemical inhibition of the RET tyrosine kinase domain

PP Knowles, J Murray-Rust, S Kjær, RP Scott… - Journal of biological …, 2006 - ASBMB
The RET proto-oncogene encodes a receptor tyrosine kinase for the glial cell line-derived
neurotrophic factor family of ligands. Loss-of-function mutations in RET are implicated in …

RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor …

G Tallini, M Santoro, M Helie, F Carlomagno… - Clinical cancer research …, 1998 - AACR
Malignant tumors of the thyroid gland vary considerably in aggressiveness, ranging from a
well-differentiated, clinically indolent, to an undifferentiated, often lethal phenotype …

RTK mutations and human syndromes: when good receptors turn bad

SC Robertson, JA Tynan, DJ Donoghue - Trends in Genetics, 2000 - cell.com
Mutations in receptor tyrosine kinases (RTKs) have been linked to an increasing number of
inherited human disease syndromes, including dwarfism, craniosynostosis, heritable cancer …

RET receptor signaling: Function in development, metabolic disease, and cancer

M Takahashi - Proceedings of the Japan Academy, Series B, 2022 - jstage.jst.go.jp
The RET proto-oncogene encodes a receptor tyrosine kinase whose alterations are
responsible for various human cancers and developmental disorders, including thyroid …